▲ +135.29% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Titan Medical in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 135.29% upside from the last price of $1.70.
The current consensus among 1 polled investment analysts is to buy stock in Titan Medical. This rating changed within the last month from a Hold consensus rating.
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.